121 related articles for article (PubMed ID: 20075512)
1. Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population.
Maver A; Medica I; Salobir B; Tercelj M; Peterlin B
Dis Markers; 2009; 27(6):295-302. PubMed ID: 20075512
[TBL] [Abstract][Full Text] [Related]
2. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
[TBL] [Abstract][Full Text] [Related]
3. The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
Lavi H; Assayag M; Schwartz A; Arish N; Fridlender ZG; Berkman N
PLoS One; 2017; 12(3):e0171945. PubMed ID: 28253271
[TBL] [Abstract][Full Text] [Related]
4. Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis.
Zhou Y; Yamaguchi E; Hizawa N; Nishimura M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Jun; 22(2):105-13. PubMed ID: 16053025
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
6. Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population.
Shang Q; Zhou C; Liu D; Li W; Chen M; Xu Y; Wang F; Bi D; Zhang X; Zhao X; Wang L; Zhu C; Xing Q
Neuromolecular Med; 2016 Jun; 18(2):232-8. PubMed ID: 27114095
[TBL] [Abstract][Full Text] [Related]
7. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.
Zhao Y; Zhang L; Mao Z; Zhang Y; Su X; Cao Y; Tang P
Med Sci Monit; 2015 Dec; 21():3875-9. PubMed ID: 26656246
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
10. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
[TBL] [Abstract][Full Text] [Related]
11. VEGF gene haplotypes are associated with sarcoidosis.
Pabst S; Karpushova A; Diaz-Lacava A; Herms S; Walier M; Zimmer S; Cichon S; Nickenig G; Nöthen MM; Wienker TF; Grohé C
Chest; 2010 Jan; 137(1):156-63. PubMed ID: 19741061
[TBL] [Abstract][Full Text] [Related]
12. Quantitative genetic study of the circulating osteopontin in community-selected families.
Ermakov S; Leonov A; Trofimov S; Malkin I; Livshits G
Osteoporos Int; 2011 Aug; 22(8):2261-71. PubMed ID: 20967421
[TBL] [Abstract][Full Text] [Related]
13. Association of osteopontin gene haplotypes with nephrolithiasis.
Gao B; Yasui T; Itoh Y; Li Z; Okada A; Tozawa K; Hayashi Y; Kohri K
Kidney Int; 2007 Sep; 72(5):592-8. PubMed ID: 17519954
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population.
Maver A; Medica I; Salobir B; Sabovic M; Tercelj M; Peterlin B
Int J Mol Med; 2007 Sep; 20(3):385-90. PubMed ID: 17671745
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer.
Lee TY; Lin JT; Wu CC; Yu CC; Wu MS; Lee TC; Chen HP; Wu CY
J Clin Gastroenterol; 2013 Jul; 47(6):e55-9. PubMed ID: 23426449
[TBL] [Abstract][Full Text] [Related]
16. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.
Maetzler W; Michelis J; Tomiuk J; Melms A; Becker C; Gasser T; Schulte C; Berg D
J Neural Transm (Vienna); 2009 May; 116(5):599-605. PubMed ID: 19340392
[TBL] [Abstract][Full Text] [Related]
18. OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.
Mi Y; Ren K; Dai F; Zhu L; Feng N
Sci Rep; 2015 Sep; 5():14164. PubMed ID: 26369832
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.
Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Ko YL
Biomark Med; 2019 Jun; 13(9):751-760. PubMed ID: 31157557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
